$15.14
-0.210 (-1.37%)
At Close: Jul 31, 2026
Schrödinger Reports Fourth Quarter and Full-Year 2025 Financial Results
04:05pm, Wednesday, 25'th Feb 2026
NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR) today announced financial results for the fourth quarter and full-year ended December 31, 2025, and provided its 2026 outlook and 2028 fina
Schrödinger to Participate in Upcoming Investor Conferences
08:30am, Tuesday, 24'th Feb 2026
NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR) today announced that management will participate in the following conferences in March: TD Cowen 46th Annual Health Care Conference: Firesi
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
08:30am, Wednesday, 18'th Feb 2026
NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR) today reported that on February 13, 2026, the company granted (i) non-statutory stock options to purchase 9,600 shares of the company's com
Schrödinger to Announce Fourth Quarter and Full-Year 2025 Financial Results on February 25
08:30am, Wednesday, 11'th Feb 2026
NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR) will report its fourth quarter and full-year 2025 financial results on Wednesday, February 25, 2026, after the financial markets close. The
The Genesis Mission Has a 270-Day Timeline – And You’re Already Late
12:00am, Tuesday, 27'th Jan 2026
The government is taking equity stakes in American companies. Here are the next Genesis Mission stocks to buy before the capital hits.
Critical Survey: Hims & Hers Health (NYSE:HIMS) versus Schrodinger (NASDAQ:SDGR)
01:15am, Thursday, 22'nd Jan 2026
Hims and Hers Health (NYSE: HIMS - Get Free Report) and Schrodinger (NASDAQ: SDGR - Get Free Report) are both medical companies, but which is the superior business? We will compare the two businesses
Market Today: Banks, Big Tech, Biopharma and Energy Move on Policy and Deals
05:34pm, Monday, 12'th Jan 2026
Guru Stock PicksJerome Dodson has made the following transactions:Reduce in ORLY by 3%Sold out in BLDRAdd in NTRA by 2.49%New position in INSMTweedy Browne Inte
Schrödinger Provides Update on Progress Across the Business and Outlines 2026 Strategic Priorities
08:30am, Monday, 12'th Jan 2026
NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR) provided an update on its progress across the business in 2025 and announced its strategic priorities for 2026. The company is continuing t
Schrodinger to offer Eli Lilly's AI drug discovery platform on its software
07:04am, Friday, 09'th Jan 2026
Schrodinger said on Friday it is collaborating with Eli Lilly to offer the pharmaceutical major's AI-based platform, TuneLab, on its drug designing software.
Schrödinger Partners with Lilly to Make TuneLab Platform Available in LiveDesign
07:00am, Friday, 09'th Jan 2026
NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR) today announced a collaboration with Lilly TuneLab™, a platform launched by Eli Lilly and Company (Lilly) designed to accelerate drug dis
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
06:15am, Saturday, 20'th Dec 2025
She and her team loaded up on two cryptocurrency-related companies. They also purchased an innovative healthcare tech stock.
The Genesis Mission Has a 270-Day Timeline – And You’re Already Late
12:00am, Saturday, 20'th Dec 2025
The government is taking equity stakes in American companies. Here are the next Genesis Mission stocks to buy before the capital hits.
Miss These Genesis Mission Stocks, and You’ll Regret It for a Decade
12:00am, Saturday, 20'th Dec 2025
The government is taking equity stakes in American companies. Here are the next Genesis Mission stocks to buy before the capital hits.
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
08:30am, Wednesday, 17'th Dec 2025
NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR) today reported that on December 15, 2025, the company granted restricted stock units (RSUs) with respect to 2,666 shares of the company's c
Schrodinger (NASDAQ:SDGR) Shares Gap Up Following Analyst Upgrade
01:29am, Tuesday, 16'th Dec 2025
Schrodinger, Inc. (NASDAQ: SDGR - Get Free Report)'s share price gapped up before the market opened on Monday after Bank of America upgraded the stock from a neutral rating to a buy rating. The stock
Sign In
Buy SDGR